Abstract | Organisms experience dramatic fluctuations in demands and stresses over the course of the day. In order to maintain biological processes within physiological boundaries, mechanisms have evolved for anticipation of, and adaptation to, these daily fluctuations. Endocrine factors have an integral role in homeostasis. Not only do circulating levels of various endocrine factors oscillate over the 24 h period, but so too does responsiveness of target tissues to these signals or stimuli. Emerging evidence suggests that these daily endocrine oscillations do not occur solely in response to behavioural fluctuations associated with sleep-wake and feeding-fasting cycles, but are orchestrated by an intrinsic timekeeping mechanism known as the circadian clock. Disruption of circadian clocks by genetic and/or environmental factors seems to precipitate numerous common disorders, including the metabolic syndrome and cancer. Collectively, these observations suggest that strategies designed to realign normal circadian rhythmicities hold potential for the treatment of various endocrine-related disorders.
Introduction
Consideration of the temporal relationship between pro cesses or events is critical for our understanding of the mol ecular basis of physiology and the pathogenesis of dis ease. Biological processes must occur in a speci fic order to prevent concurrent activation of potentially incompatible mechanisms. The outcome can be cata strophic if this level of control becomes impaired, often resulting in pathology. Temporal regulation is obser ved at multiple timescales, ranging from seconds (for example, ion homeo stasis) to years (for example, develop ment). One timescale that has received increasing attention over the past few decades is the circadian (24 h) period. Rejuve nated enthusiasm in chrono biology has been fuelled, in part, by identification of the molecu lar underpinnings of the mammalian circa dian time keeping mecha nism. This mechanism orches trates a plethora of critical biological functions, including processes that precipitate death.
Endocrine factors are undoubtedly at the heart of circa dian biology. The generation, secretion and abundance of various endocrine factors are subject to stringent and often predictable timeofdaydependent control, as is the sensi tivity of target organs to these signals. Emerg ing evidence strongly suggests that these rhythms are driven not only by behaviourassociated factors but also by an intrin sic time keeping mechanism known as the circa dian clock. This article reviews the importance of circadian clock control of endocrine factors. Following a general overview of known oscillation characteristics of endocrine factors, we discuss evidence regarding mediation of endocrine rhythms by circadian clocks, the pathologies associated with disrup tion of normal rhythmicity and the tactics used to restore orchestration of circadian processes.
Stimulus-response coupling
By definition, hormones and endocrine factors are sub stances produced in one organ or cell type that act at a site that is distinct from the origin. As such, these factors are critical for communication between organs (for exam ple, between the central nervous system and peripheral tissues) in complex species, such as humans and other verte brates. Such communication is essential for main tenance of homeostasis and adaptation to environmental changes or stresses.
A substantial body of evidence suggests that various components of the endocrine system exhibit timeofday dependent rhythms, facilitating anticipation of and/or adaptation to environmental and behavioural fluctuations. In principle, cellular hormone action is governed by the concentration of the hormone relative to its affinity for its specific receptor, the abundance and/or avail ability of the receptor, and the activity status of postreceptor signal ling components, including mechanisms of desensitization or downregulation of hormone signalling. Timeofday exerts a modulatory effect on all of these governing mec hanisms. Here, we provide a brief summary of what is known regarding 24 h rhythms in the level of the stimu lus (that is, endocrine factors) and responsiveness of the target tissue. Box 1 defines commonly utilized terms in the field of ch ronobiology, many of which are included in this Review.
or behavioural factors, such as light-dark and feedingfasting cycles, which typically occur in timeofday dependent patterns. 6, 7 Figure 1 and Table 1 summarize what is known regarding timeofdaydependent oscilla tions in these and other endocrine factors, and below we provide additional details for several of these factors.
Melatonin
Circulating melatonin is produced in the pineal gland, under tight control by the central circadian pacemaker in the suprachiasmatic nucleus (SCN) region within the hypothalamus. 8 A primary function of melatonin is to relay information regarding the environmental light-dark cycle (especially in response to changes in day length) to trigger the relevant endocrine changes. 9 Melatonin pro duction is characteristically low in the presence of light and increases during the night, during which time it induces and supports sleep. 10 Importantly, additional, sleepindependent functions of this hormone have been reported, including modulation of vascular reactivity, anticonvulsant and antioxidant functions. 11 Interestingly, melatonin deficiency is associated with an increased inci dence of colorectal and breast cancer, and polymorphisms in melatonin receptors are associated with an increased risk of type 2 diabetes mellitus (T2DM). 10, 12 Melatonin
Key points ■ Various endocrine factors are known to exhibit time-of-day-dependent oscillations in both humans and animals ■ Endocrine factor rhythms are driven not only by environmental and behavioural influences, but also by intrinsic circadian clocks ■ Circadian dyssynchrony is associated with multiple pathologic states, including cardiometabolic diseases and cancer ■ Reinstatement of circadian synchrony through time-of-day-restricted feeding and pharmacologic strategies improves metabolic homeostasis supplementation has been used in the clinical setting for the treatment of patients with seasonal affective disorder and numerous sleep disorders, as well as being an adjuvant therapy for epilepsy. 13, 14 Cortisol and the HPA axis Release of cortisol from the adrenal cortex is under the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. 15 Corticotropinreleasing hormone is a component of this axis that is secreted by the hypothalamus and conveyed via the hypophyseal portal vasculature to the anterior pituitary gland. There, corticotropinreleasing hormone triggers the release of adreno corticotropic hor mone (ACTH) into the general circulation; upon binding to receptors in the adrenal gland, ACTH stimulates cor tisol release. Cortisol levels exhibit a robust timeofday dependent rhythm in humans, normally peaking dur ing the morning (0700-0800 h). 16 In doing so, this cata bolic hormone is believed to prepare the body for typi cal stresses associated with waking (for example, energetic demand); the steady rise in cortisol levels during the sleep phase is consistent with its role in anticipation of wakefulne ss and increased activity. 15, 16 Growth hormone GH is produced in the anterior pituitary and secreted in response to the integrated stimulatory and inhibi tory effects of GHreleasing hormone and somatostatin, respectively, both of which emanate from the hypothala mus. 17, 18 GH has specific and powerful effects in metabo lism, typically in opposition to insulin (for example, decreasing glucose utilization and increasing lipolysis). 19 Circulating levels of GH exhibit both circadian and ultra dian variation, as well as sexual dimorphism. In women, GH is secreted in frequent nondiscrete peaks of fairly uniform amplitude throughout the day, with increased peak amplitude at night (during sleep). During the day in men, GH is secreted in pulses that are less frequent but more discrete than those in women, again with increased peak amplitude at night. 1, 20 This sexual dimorphism is also observed in children, with peak amplitude in GH secretion in both the day and night being greater than that in adults. 21, 22 Although the exact purpose of increased GH availability at night is unknown, possibilities include pro motion of insulin resistance, mobilization of triglycerides, and promotion of protein synthesis and repair.
Adiponectin
Adiponectin is one of several adipokines (that is, a dipose derived endocrine factors) that exhibits a timeofday dependent rhythm in humans, peaking in the circulation between 1200 h and 1400 h. 7, 23 Adiponectin is best known as an insulin sensitizer, with circulating levels that vary inversely with BMI. 24 Interestingly, hypo adiponectinae mia is associated with an increased risk of the metabolic syndrome, but, conversely, raised levels of adiponectin are associated with an increased risk of chronic heart failure and chronic renal failure. 24 The pur pose of increased adipo nectin secretion during the early afternoon is unclear, but this rhythm might provide anticipation of
Box 1 | Definitions of chronobiology terms
Tau (period): the length of time for one cycle of an oscillation to repeat. For example, the length of time for a distinct phase point (such as the peak) to re-occur during the subsequent cycle. Amplitude: the size of an oscillation as measured by half the distance from the peak to the trough. Phase: the timing of a consistent point in the cycle, such as the peak or trough. Phase shift: a change in phase such that it occurs earlier or later, owing to a displacement of the entire cycle. A stable phase shift will only produce a period change for one or a few 'transient' cycle(s), after which the oscillation will continue with the same period as before the shift. Zeitgeber: literally means 'time giver' and refers to any resetting stimulus that serves as a time cue for the external environment. Light and food intake are classic examples of zeitgebers for the suprachiasmatic nucleus (SCN) and non-SCN clocks, respectively. Circadian rhythm: circadian literally means 'about a day' and refers to a rhythm whose complete cycle repeats close to every 24 h. In order to demonstrate that a circadian rhythm is endogenously generated, the rhythm must be measured under constant conditions (that is, in the absence of a zeitgeber). Diurnal rhythm: a physiological measurement (for example, gene transcription, protein expression, body temperature, behaviour) that exhibits daily changes across the 24 h light-dark cycle such that the peak(s) and nadir occur ~12 h apart or in a frequency that is a harmonic of 24 h. In conditions in which a zeitgeber is present (for example, a light-dark cycle), it is impossible to tell if a diurnal rhythm is endogenously generated or an acute response to the zeitgeber.
increased insulin levels later in the day (thereby promotin g insulin action).
Insulin
Insulin is produced by the β cells of the pancreatic islets, and is secreted in response to increased levels of circulat ing nutrients, particularly glucose. 25 Its primary function is at the level of metabolism, stimulating glucose utilization and protein synthesis by tissues such as the liver, skeletal muscle and adipose tissue. 26 This anabolic hormone also inhibits fatty acid oxidation and stimulates the produc tion of triglycerides from fatty acids. 26 Insulin secretion displays a diurnal rhythm in humans, peaking at roughly 1700 h (with a nadir at 0400 h). 6 Such a rhythm is con sistent with nutrient storage during the awake and fed state, with subsequent mobilization during the asleep and fasting period.
Daily oscillations in sensitivity
In contrast to information concerning circulating levels of hormones and endocrine factors, our understand ing of the effect of time of day on endorgan hormonal sensitivity is less well developed. Standard techniques of evaluation make this variable difficult to study, especially in humans. How ever, a few examples exist in which time ofdaydependent rhythms in hormone sensitivity have been charac terized, including responsiveness to ACTH and insulin. As mentioned previously, cortisol exhibits a robust diurnal variation in humans. However, this rhythm does not seem to be driven by fluctuations in ACTH levels; by contrast, the sensitivity of the adrenal cortex to ACTH is dependent on the time of day, thereby mediating cortisol oscillations. 15 Glucose homeostasis also exhibits interesting time ofdaydependent changes, particularly in humans. For example, the 'dawn phenomenon' occurs in all indi viduals and is exaggerated in individuals with diabetes mellitus. [27] [28] [29] [30] [31] This phenomenon is characterized by a spon taneous increase in plasma levels of glucose and/or insulin requirement without nutrient intake before awaken ing (typically at 0500-0800 h). This increase is believed to arise from increased hepatic production of glucose that prompts (or requires) increased insulin levels to ensure glucose disposal and restrain hepatic glucose production. Whilst the rise in hepatic production of glucose corres ponds temporally to rising levels of cortisol, epinephrine and norepinephrine (all counterregulatory hormones), experiments in humans indicate that the dawn phenome non is not accounted for by increases in the levels of these hormones, but rather to antecedent surges of GH earlier in the nocturnal period.
27,32

Mediators of circadian rhythms
Intrinsic versus extrinsic influences Daily rhythms in the abundance of many endocrine fac tors (as well as in the sensitivity of distinct tissues to these factors) are potentially mediated by a combination of influences. A classic view has been that fluctuations in nutrient levels, haemodynamic stresses, body tem perature, metabolism, sympathetic and autonomic tone, as well as the levels of various autocrine and paracrine factors are mediated by behavioural changes across the sleep-wake and feeding-fasting cycles. [33] [34] [35] How ever, this 'extrinsic' concept has been challenged in the past few decades, as a wealth of evidence from both human and animal studies is consistent with a contribution of an intrinsic timekeeping mechanism towards the production of these oscillations.
Elegant studies by Van Cauter and colleagues were among the first to assess the contribution of sleep to oscillations in the levels of a number of endocrine factors in humans. A state of arousal was enforced in the par ticipants of these studies during the night, so that they slept during the following day. [36] [37] [38] These studies revealed that oscillations in the levels of some endocrine factors (for example, cortisol and TSH) occur independently of sleep-wake cycles, whereas oscillations in the levels of other endocrine factors are dependent on sleep-wake cycles (for example, GH and prolactin). This finding raised the possibility that fluctuations in the levels of distinct endocrine factors over the course of the day are driven, at least in part, by an endogenous mechanism (that is, independent of behavioural rhythms). Similarly, other groups have begun to dissociate the relative contri bution of intrinsic versus extrinsic influences on biologi cal processes in humans, through enforcement of multiple 20 h or 28 h sleep-wake cycles. [39] [40] [41] [42] These studies have successfully uncovered the contribution of the intrinsic circadian system on daily rhythms of multiple endocrine factors, including epinephrine and plasminogen activator inhibitor 1.
The endogenous circadian system in mammals is the circadian clock. 43, 44 Circadian clocks are cellautonomous molecular mechanisms that enable a cell to perceive the time of day. In doing so, molecular clocks are able to alter 
REVIEWS
biological processes over the course of the day, independ ent of extracellular stimuli or stresses. Circadian clocks are classically described as being transcriptional in nature, composed of a collection of transcriptional modulators that interact to form positive and negative regulatory feedback loops. 43, 44 At the heart of the circadian clock mechanism are two transcription factors, CLOCK (circadian locomotor output cycles protein kaput) and BMAL1 (also known as aryl hydrocarbon receptor nuclear translocatorlike protein 1). Heterodimers of these two transcription factors bind to highly conserved E box response ele ments within the promoters of multiple target genes and modulate gene expression. 45, 46 The translation products of a number of these target genes are themselves core clock components, which feedback upon CLOCK-BMAL1 activity, including the PER1-3, CRY1 and CRY2 pro teins. 47, 48 An additional wellestablished negative feedback loop involves REVERBα, which negatively influences BMAL1 at the transcriptional level. 49 Those genes that are regulated by the circadian clock but do not directly influence the activity of core clock com ponents are termed clockcontrolled genes or out put genes. An estimated 7-13% of the transcriptome of a cell is under circadian control, including genes that encode modulators of transcription, signal transduction, protein turnover and metabolism; through fluctuations in the expression of clockcontrolled genes, the circadian clock influences cellular and organ function in a timeof daydependent manner. [50] [51] [52] The circadian clock is often described as a transcriptional mechanism; however, a host of posttranslational modifications are essential for its normal function, including phosphorylation, ubiquitina tion, SUMOylation, acetylation, ADPribosylation and OGlcNAcylation. [53] [54] [55] [56] [57] [58] Many of these posttranslational modifications not only facilitate exquisite sensitivity of the clock mechanism to numerous extracellular factors (ensuring rapid entrainment to alterations in the environ ment) but also serve as an additional means by which the clock influences cellular processes. Interestingly, in the past few years, O'Neill et al. have described a highly conserved circadian mechanism that is independent of transcription. 59 Redox biology is at the core of this ances tral clock mechanism, which can be monitored through oscillations in the oxidative state of peroxiredoxin.
Influence of the SCN versus non-SCN clocks
Circadian clocks can be broadly divided into two major classes: the central clock within the SCN and peripheral (or nonSCN) clocks. 43 In a classic series of lesion and transplant studies, the central circadian pacemaker (local ized to the SCN of the hypothalamus) was established as the orchestrator of the intrinsic circadian system in mam mals. Specifically, lesions of the SCN result in severe arrhythmicity of multiple biological functions, including sleep-wake behaviour, drinking, food intake, oxygen consumption and stool output, as well as adrenal, pineal and pituitary hormone release. [60] [61] [62] Transplantation of fetal SCN tissue into the third ventricle of rodents whose SCN has been ablated reinstates locomotor rhythms with the rate of the donor clock tissue. [63] [64] [65] Even when SCN grafts are encapsulated such that only diffusible factors are exchanged between the SCN and its environment, behavioural rhythmicity is restored, which suggests that the SCN output signal involves, at least in part, a para crine endocrine signal. 64 One releasable factor thought to be involved in signalling rhythmic locomotor behav iour is prokineticin2. 66 Transplantation does not restore rhythmic release of gluco corticoids, melatonin or lutein izing hormone, which demonstrates that many endocrine rhythms require a neural connection. 60 Advances over the past few decades have dem onstrated that the circadian network is in reality a multiple oscil lator system, in which different tissues and cells are capable of exhibiting selfsustained oscillations in isola tion (although oscillations tend to dampen after several days for nonSCN tissue cultures). [67] [68] [69] [70] This realization has raised the possibility that circadian rhythms in various biological processes are driven in part by local tissue oscil lators. Although mela tonin rhythmicity is un doubtedly dependent upon cen tral SCN clock control, 71 peripheral clock control is evi dent in other peripheral endocrine tissues, such as the adrenal gland and pancreas (Figure 2 ). For example, trans plantation of Per2 -/-Cry1 -/-adrenal glands into wildtype mice results in a dampened rhythm of cortico sterone release, despite normal ACTH levels. 72 Simi larly, in mice with adrenalspecific knockdown 
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Time-of-daydependent rhythm
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Cortisol Yes 0700-0800 h Kalsbeek et al. 16 Carroll et al. 3 GH Yes Pulsatile secretion, with increased amplitude at night
Avram et al. 1 Jaffe et al. 20 Villadolid et al. 21 Goji et al. (experimentally produced reduction of protein expres sion) of BMAL1, arrhythmic plasma corticosterone secretion occurs. 73 Taken together, these data sug gest that the adrenal mol ecular clock locally regulates ACTH sensi tivity (although it should be noted that ACTH sen sitivity is also dependent on SCN signals transmitted by sy mpathetic fibres). 15 Evidence also supports the concept that the pancre atic βcell clock influences insulin secretion. Allaman Pillet et al. reported that synchronized β cells in culture secrete insulin in a rhythmic fashion, with a periodicity of 24 h. 74 Moreover, mice with a BMAL1 deficiency only in pancreatic β cells display impaired insulin secretion. 75, 76 These results suggest that distinct peripheral clocks have a critical role in many endocrine tissues, and that dis ruption of these molecular clocks results in impaired endocrine function.
Pathologies of circadian disruption
Animal models of impaired circadian biology As highlighted previously and in Table 1 , it is clear that a large number of endocrine factors exhibit timeof daydependent oscillations in both humans and animal models. Furthermore, cell autonomous circadian clocks seem to contribute towards these rhythms to varying degrees. Observations such as these raise a host of criti cal questions, for which the answers are not clear. For example, what is the physiological purpose of daily oscil lations in endocrine factors, and what is the pathological consequence of disruption of these oscillations? Impairment of normal circadian rhythmicity negatively affects a host of biological processes in both humans and animal models. 43, [77] [78] [79] Circadian disruption can occur secon darily to changes in the environment (for example, fluctuations in the light-dark, feeding-fasting or sleepwake cycles) and/or genetic abnormalities. The estrous cycle and conception success serves to illustrate this concept. Circadian disruption during night shift work is associated with alterations in menstrual function. 80 In mouse models, modulation of the light-dark cycle, disrup tion of SCN and the pre optic communication, or genetic manipulation of either CLOCK or BMAL1 all impede estrous cycling and successful pregnancies. [80] [81] [82] [83] [84] Next, we summarize key findings from experimental models that illustrate the pathological effects of disrupted circadian rhythms on endocrine systems.
Manipulation of the light-dark cycle has proven to be a useful tool for the study of disrupted circadian rhythms in many biological processes, including endocrinerelated and metabolismrelated parameters. Following an abrupt alteration in the light-dark cycle, intrinsic circadian clocks reset at varying rates, in an attempt to resynchronize to the new environment. The SCN resets fairly rapidly to a large shift in the light-dark cycle (at a rate of ~1 day per hour of shift in the light-dark cycle), in contrast with periph eral organs, which invariably reset at a slower rate than the SCN. [85] [86] [87] [88] Accordingly, dys synchrony occurs between the organism and the environ ment, as well as between differ ent organs, until all clocks (and clockregulated processes) reset fully to the new light-dark cycle.
Chronic dyssynchrony ensues if light-dark cycles are altered multiple times in succession, with an interval shorter than that required for complete resynchroniza tion. This type of dyssynchrony occurs in an experi mental jet lag protocol, wherein the light-dark cycle is phaseadvanced 6 h either once or twice a week. Long term periods of dyssynchrony are associated with altered immune function, increased tumour growth, reduced body temperature and increased adiposity in animal models. [89] [90] [91] [92] Additional models of circadian dyssynchrony induced by light-dark cycle manipulation include hous ing rodents in constant light or shortened daily cycles (for exam ple, 20 h days). 93 Invariably, these manipulations nega tively affect endocrineregulated processes, in cluding metabolic homeostasis. [94] [95] [96] [97] [98] [99] The unveiling of core components of the mammalian circadian clock mechanism over the past two decades has been followed closely by their genetic manipulation and characterization of the phenotypic consequence in rodents. One of the first clock components to be geneti cally modified was CLOCK; chemical muta genesis resulted in a truncated dominant negative mutant CLOCK protein lacking the transactivation domain. 100 Interestingly, although mice with the mutated CLOCK protein exhibit normal activity rhythms under light-dark cycles, feeding behaviour seems to be altered, which is associated with increased adiposity and perturbations in endocrine factors (for example, insulin levels). 101 Both germline and tissuerestricted knockout mice have also been generated for distinct circadian clock components. Of these models, germline Bmal1 knockout mice exhibit one of the most striking phenotypes, being arrhythmic for most parameters under circadian condi tions and developing markers of accelerated ageing (for example, sarcopenia, cataracts and lipoatrophy), con comitant with a reduced lifespan. 102 In terms of endocrine factors, Kennaway and coworkers have reported that cir culating levels of insulin are decreased, whereas levels of adiponectin and leptin are increased, in Bmal1 null mice (relative to wildtype mice). 103 Indeed, it has been sug gested that Bmal1 null mice should be considered as a Peripheral circadian clocks are entrained (reset) by both SCN-dependent regulation (for example, secretion of prokineticin-2, neural stimulation) and behaviouraldependent influences, such as feeding and physical activity. Circadian clocks within the adrenal cortex contribute to diurnal variations in cortisol release by modulating sensitivity to adrenocorticotropic hormone, and the β-cell circadian clock seems to be similarly critical for insulin secretion. In addition, circadian clocks within target tissues (for example, adipose, liver and skeletal muscle) potentially modulate sensitivity to endocrine factors in a time-of-day-dependent manner. Abbreviation: SCN, suprachiasmatic nucleus.
model of T2DM, wherein insulin insufficiency contributes to hyperglycaemia. 75, 76 Genetic manipulation of circadian clock components invariably alters insulin sensitivity, in a manner that is dependent upon which specific circa dian clock component is disrupted, which leads to either increased or decreased insulin sensitivity. 104, 105 Endocrine circadian abnormalities in humans Misalignment of peripheral and central clocks with behav ioural sleep-wake rhythms can be experimentally induced in the laboratory setting by the use of a very short day (20 h; 7 h of sleep and 13 h of wakefulness) or a very long day (28 h; 8 h of sleep and 20 h of wakefulness) that is outside the range of entrainment for a 24 h clock. 106 For example, three cycles of an enforced 28 h sleep-wake schedule result in sleep-wake behaviour that is ~180° out of phase with the intrinsic circadian clock and behav iour. 106 After three additional cycles, behaviour and the circadian clock are back in alignment.
Thus, comparison of cycles with full alignment versus misalignment provides the opportunity to determine which endocrine rhythms follow sleeping, waking or eat ing behaviour, and which rhythms are directly coupled to the intrinsic circadian clock. By use of this 28 h sleepwake protocol, Scheer et al. found that glucose, epi nephrine and cortisol faithfully follow a ~24 h rhythm during behavioural misalignment, whereas leptin, insu lin and norephinephrine do not; however, it is important to note that all of these endocrine rhythms were influenced to varying degrees by the behavioural cycle. 107 Overall, levels of leptin were lower during misaligned than aligned conditions in the experiments of Scheer and coworkers, similar to when circadian misalignment is induced by a subtle approach using a 24.6 h sleep-wake schedule. 108 Participants exposed to this schedule for 25 days exhibited physiologically reduced leptin levels, which will probably result in a metabolic outcome. In fact, after just three cycles of laboratoryinduced circa dian misalignment (that is, a 28 h day), healthy volun teers show a dramatic decrease in the number of genes with 24 h rhythmic expression in blood cells. 109 Importantly, this same protocol also causes glucose intolerance and insulin resistance, which suggests that circadian mis alignment could cause insufficient βcell compensa tion. 107 In the past year, Leproult and co workers have reported that when circadian misalignment is imposed on sleepdeprived individuals, indices of insulin resist ance worsen. 110 Taken together, these studies are consist ent with the concept that circadian misalignment impairs endocrine and metabolic homeostasis.
Aberrant metabolic homeostasis associated with experimental circadian misalignment is reminiscent of the metabolic perturbations induced in shift workers. Clearly, misalignment of melatonin and cortisol rhythms occurs during shift work. [111] [112] [113] In addition, shift workers have an increased risk of developing cardiometabolic dis eases. 114 The increased risk could be related to increased post prandial levels of insulin, glucose and triacylglycerol during the night shift. 115 Furthermore, increased energy intake and circulating levels of triglycerides, as well as reduced insulin sensitivity and postprandial ghrelin release, have been observed in night workers. 116 Shift workers also have an increased risk of developing cancer, gastro intestinal disorders and cardiovascular diseases such as ischaemic heart disease. 107, 114, [117] [118] [119] [120] In summary, these observations underscore the importance of understand ing synchronization of the endogenous circadian system with environmental, behavioural and endocrine factors.
In addition to circadian misalignment induced by environ mental or lifestyle influences, evidence suggests that dyssynchrony among intrinsic oscillators occurs dur ing pathological states, particularly those associated with endocrine dysfunction. For example, clock gene rhythms in white blood cells are dampened in patients with T2DM. 121 Interestingly, patients with T2DM do not show a circadian rhythm in insulin secretion, although rhythmicity in insulin sensitivity seems to remain intact. 122 Even firstdegree relatives of patients with T2DM show dampened and shortened rhythms in insulin secre tion rates. 123 These clinical observations are supported by findings in rodent models of metabolic dysfunction, revealing that circadian clock and metabolic perturba tions occur in parallel. [124] [125] [126] [127] [128] Furthermore, a shortterm, highfat diet in mice disrupts alignment of circadian clock gene rhythms in multiple tissues before the onset of metabolic dysfunction, which suggests that circadian misalignment precedes (and potentially causes) metabolic and endocrine abnormalities. 129, 130 Restoring circadian rhythmicity Clock gene rescue studies in animal models As mentioned previously, disruption of the molecular clock in animal models can result in endocrine disrup tion and cardiometabolic impairment. Genetic rescue of clockcontrolled gene transcription rhythms and associ ated metabolic and endocrine phenotypes would not only serve as a proofofprincipal but also shed light on the feasibility of targeting this system for future treatment of disease states. For example, abnormalities observed in arrhythmic wheel running activity, metabolism, body weight and adiposity in Bmal1 knockout mice can be rescued by germline overexpression of Bmal2. 131 In addi tion, the low body weight and early death phenotypes of Bmal1 knockout mice can be rescued by muscle specific, but not brainspecific, overexpression of Bmal1. 132 Rhythmicity of a number of clockcontrolled genes is also restored by genetic rescue with musclespecific Bmal1. 132 Of note, a subset of transcriptional rhythms normally display 12 h periodicity in peripheral tissues such as the liver, heart, kidney and lungs in wildtype mice. 133 However, these 12 h rhythms become 24 h rhythms when Clock expression is restored in the brains of Clock mutant mice. 134 This finding is interesting in light of the fact that timeofdayrestricted feeding (during the in active period, 1-9 h after lights are on) in wildtype mice also converts these shorter, ultradian rhythms to 24 h rhythms. 133 Taken together, these studies suggest that circadian dys synchrony can be rescued, and that the central clock inter acts with environmental and systemic signals to produce ultradian rhythms.
The use of time-of-day-restricted feeding Evidence to date indicates that the intrinsic circadian system has an important role in daily rhythms of a host of endocrine factors. In several cases (for example, cor tisol and insulin), the nonSCN clocks seems to contrib ute substantially. This knowledge raises the question of whether strategies designed to selectively entrain periph eral circadian clocks would be beneficial for resynchro nizing oscillations in endocrine factors during dis ease states (such as cardiometabolic disease states). Damiola and coworkers were among the first to report that restricting food access in rodents to a distinct period dur ing the sleep phase causes a phase shift in circadian clocks within peripheral tissues such as the liver, kidneys, pan creas and heart, whereas the SCN clock remains entrained to the light-dark cycle. 135 The strength of this intervention is exemplified by the demonstration that oscil lations in the expression of circadian clock genes are reinitiated in peripheral tissues of Clock mutant mice by timeofdayrestricted feeding. 136 These initial studies led to various investigations into the negative effect on energy homeostasis of circadian dyssynchrony induced by restricted feeding. A consen sus of these studies is that consumption of an inappro priately large number of calories during the end of the active period and/or during the sleep phase is associ ated with metabolic dyssynchrony and cardiometabolic disease development. 95, [137] [138] [139] [140] [141] Importantly, evidence exists that observations in rodent models translate to humans. For example, night eating syndrome is associated with obesity. 142 In addition, Qin et al. have reported that con sumption of a large meal at night leads to an uncoupling of the relationship between plasma levels of glucose and insulin, which is indicative of metabolic dysfunction. 143 On the basis of these findings, several investigators have hypothesized that restriction of food intake to an appro priate time of the day in individuals with cardio metabolic disease states could prove beneficial, by resetting periph eral clocks and reestablishing circadian synchrony.
In support of such a concept, Kudo et al. reported that restricting food access to the active phase in db/db mice normalized liver clock function, and concomitantly improved various cardiometabolic parameters (including lowering circulating levels of insulin). 127 Similarly, active phaserestricted feeding is able to normalize oscillations in the expression of circadian clock genes in periph eral tissues concomitant with metabolic and endocrine abnormalities in both a rodent model of shift work and during chronic highfat feeding in mice. 137, 141, 144 Clearly, additional studies are required to elucidate further the potential utility of timeofdayrestricted feeding for normalization of circadian dyssynchrony and associated metabolic or endocrine abnormalities.
Potential pharmacological approaches
Treatment strategies involving genetic manipula tion or alterations in a patient's daily behaviour are clearly not ideal, for a multitude of reasons. A more promis ing therapeutic approach would be to use a pharmaceuti cal agent that selectively targets the molecular clock. 145 One small molecule compound called longdaysin has been identified in a chemical screen that lengthens the circadian period both in vitro and in vivo by targeting multiple kinases simultaneously, leading to PER1 degra dation. 146 Stabilization of CRY proteins (through preven tion of ubiquitination and degradation) by another small molecule (KL001) also lengthens the period of the clock in vitro. 147 Interestingly, KL001 is a potentially attractive therapeutic prospect for the treatment of T2DM, as it has been shown to suppress hepatic glucose production induced by glucagon. 147 Additional clock components are known to affect metabolism, including REVERBα. Agonists of REVERBα (SR9009 and SR9011) enhance Per2 rhythms, sup press Cry2 rhythms and shift Bmal1 rhythms; SR9009 also rescues increased adiposity, dyslipidaemia and hyper glycaemia in a mouse model of obesity. 148 Inhibitors of proteins encoded by clockcontrolled genes such as glyco gen synthase kinase 3 and cJun Nterminal kinases are also effective at changing the period of molecular clocks. 149, 150 When coupled with timeofdayspecific delivery, many of these small molecule inhibitors might have therapeutic potential, by restoration of circadian syn chrony of biological processes, including secretion of, and sensitivity to, endocrine factors.
Conclusions
Circulating levels of various endocrine factors exhibit a timeofday dependence. These rhythms are not solely the result of environmental or behavioural influences, as the endogenous circadian system contributes con siderably towards the production and maintenance of these endocrine rhythms. Mounting evidence suggests that cellautonomous circadian clocks modulate levels of endocrine factors, as well as tissue responsiveness to these stimuli, over the course of the day. Disrupted orchestra tion of circadian and endocrine rhythms occurs readily through environmental and/or genetic perturbation, resulting in a state of circadian dyssynchrony, which is known to promote a host of pathologies, including cardio metabolic diseases and cancer. Initial studies designed to reinstate circadian synchrony through environ mental (for example, timerestricted feeding) and/or pharmacologi cal means show promise for attenuated pathogenesis in animal models. With the identification of small molecule modulators of the circadian clock mechanism in the past few years, the prospect of therapeutically targeting this mechanism in patients with endocrine disorders holds great potential.
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